Burk Holdings
CRL icon

Burk Holdings’s Charles River Laboratories CRL Stock Holding History

Burk Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.24K Buy
11
+2
+22% +$527 ﹤0.01% 471
2026
Q2 		$2.04K Hold
9
– – ﹤0.01% 501
2026
Q1 		$1.55K Buy
+9
New +$1.67K ﹤0.01% 549

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Burk Holdings's CRL Position: Q3 2026 in Review

Burk Holdings increased its Charles River Laboratories (CRL) stake by 22% in Q3 2026, buying an estimated $527 and bringing the position to 11 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

Burk Holdings first reported a position in CRL in Q1 2026 and has held it in 3 quarters since. 353 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Burk Holdings held 11 shares of Charles River Laboratories worth $3.24K as of Q3 2026.
  • Burk Holdings bought 2 Charles River Laboratories shares in Q3 2026, an estimated $527.
  • Charles River Laboratories made up ﹤0.01% of Burk Holdings's portfolio in Q3 2026, its #471 holding.
  • Burk Holdings first reported a position in Charles River Laboratories in Q1 2026 and has held it in 3 quarters since.
  • 353 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Burk Holdings's 13F filing for Q3 2026, filed 5 Nov 2026.